Flywheel provides a medical imaging data management and analysis platform used by pharmaceutical companies and academic medical centers to organize, curate, and analyze imaging data for research, clinical trials, and AI model development. The company says 10 of the top 20 global pharmaceutical companies and 10 of the top 20 academic medical centers use its platform, and it reported 43% year-over-year growth in new business in 2025. Flywheel was founded in 2015 out of a Stanford research collaboration, incubated by Minneapolis venture studio Invenshure.
Builder’s Brief
Flywheel is a data tool on Falcoscan. Medical imaging data platform powering AI model development for research. Falcoscan rates Flywheel with an Opportunity score of 72/100, a Saturation score of 33/100, and a Wrapper-risk score of 12/100. Market signal: rising. Flywheel is founded in 2015, currently at Series_d_plus stage. Pricing: Paid.
Market position · Data
How Flywheel compares in Data
Flywheel's opportunity score of 72 ranks #73 of 354 live Data tools on Falcoscan, 3.7 points above the category average of 68.3. Its saturation score is 33/100, against a category average of 33.1. 129 of the 354 live Data tools carry a hot signal, and Falcoscan has recorded 15 shutdowns in the category.